Chemoinformaics analysis of 3,5-bis(1,1-dimethylethyl)-4-hydroxy-Methyl Ester
| Molecular Weight | 264.365 | nRot | 1 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 7 |
| Exact Molecular Weight | 264.173 | nRing | 1 |
| Solubility: LogS | -5.236 | nHRing | 0 |
| Solubility: LogP | 4.587 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 45.129 |
| nHD | 1 | BPOL | 26.681 |
| QED | 0.785 |
| Synth | 2.125 |
| Natural Product Likeliness | 0.023 |
| NR-PPAR-gamma | 0.603 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.986 |
| Pgp-sub | 0.003 |
| HIA | 0.182 |
| CACO-2 | -5.01 |
| MDCK | 0.0000141 |
| BBB | 0.234 |
| PPB | 0.99565 |
| VDSS | 2.398 |
| FU | 0.0624127 |
| CYP1A2-inh | 0.924 |
| CYP1A2-sub | 0.945 |
| CYP2c19-inh | 0.691 |
| CYP2c19-sub | 0.662 |
| CYP2c9-inh | 0.702 |
| CYP2c9-sub | 0.848 |
| CYP2d6-inh | 0.715 |
| CYP2d6-sub | 0.675 |
| CYP3a4-inh | 0.475 |
| CYP3a4-sub | 0.402 |
| CL | 7.16 |
| T12 | 0.616 |
| hERG | 0.009 |
| Ames | 0.01 |
| ROA | 0.081 |
| SkinSen | 0.337 |
| Carcinogencity | 0.033 |
| EI | 0.923 |
| Respiratory | 0.359 |
| NR-Aromatase | 0.106 |
| Antiviral | Yes |
| Prediction | 0.749708 |